Your browser doesn't support javascript.
loading
First-in-human study of oleclumab, a potent, selective anti-CD73 monoclonal antibody, alone or in combination with durvalumab in patients with advanced solid tumors.
Bendell, Johanna; LoRusso, Patricia; Overman, Michael; Noonan, Anne M; Kim, Dong-Wan; Strickler, John H; Kim, Sang-We; Clarke, Stephen; George, Thomas J; Grimison, Peter S; Barve, Minal; Amin, Manik; Desai, Jayesh; Wise-Draper, Trisha; Eck, Steven; Jiang, Yu; Khan, Anis A; Wu, Yuling; Martin, Philip; Cooper, Zachary A; Elgeioushi, Nairouz; Mueller, Nancy; Kumar, Rakesh; Patel, Sandip Pravin.
Affiliation
  • Bendell J; Sarah Cannon Research Institute, Nashville, TN, USA. Johanna.bendell@roche.com.
  • LoRusso P; Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd, Basel, Switzerland. Johanna.bendell@roche.com.
  • Overman M; Yale University Cancer Center, New Haven, CT, USA.
  • Noonan AM; University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Kim DW; Ohio State University, Wexner Medical Center, James Comprehensive Cancer Center, Columbus, OH, USA.
  • Strickler JH; Seoul National University Hospital, Seoul, South Korea.
  • Kim SW; Duke University Medical Center, Durham, NC, USA.
  • Clarke S; Asan Medical Center, Seoul, South Korea.
  • George TJ; Royal North Shore Hospital, St. Leonards, NSW, Australia.
  • Grimison PS; University of Florida Health Cancer Center, Gainesville, FL, USA.
  • Barve M; Chris O'Brien Lifehouse, Camperdown, NSW, Australia.
  • Amin M; Mary Crowley Cancer Research, Dallas, TX, USA.
  • Desai J; Washington University School of Medicine, St. Louis, MO, USA.
  • Wise-Draper T; Dartmouth-Hitchcock Medical Center, Norris Cotton Cancer Center, Lebanon, NH, USA.
  • Eck S; Royal Melbourne Hospital, Parkville, VIC, Australia.
  • Jiang Y; University of Cincinnati Cancer Center, Cincinnati, OH, USA.
  • Khan AA; AstraZeneca, Gaithersburg, MD, USA.
  • Wu Y; AstraZeneca, Gaithersburg, MD, USA.
  • Martin P; AstraZeneca, Gaithersburg, MD, USA.
  • Cooper ZA; AstraZeneca, Gaithersburg, MD, USA.
  • Elgeioushi N; AstraZeneca, Gaithersburg, MD, USA.
  • Mueller N; AstraZeneca, Gaithersburg, MD, USA.
  • Kumar R; AstraZeneca, Gaithersburg, MD, USA.
  • Patel SP; AstraZeneca, Gaithersburg, MD, USA.
Cancer Immunol Immunother ; 72(7): 2443-2458, 2023 Jul.
Article in En | MEDLINE | ID: mdl-37016126
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Non-Small-Cell Lung / Lung Neoplasms / Antineoplastic Agents Limits: Humans Language: En Journal: Cancer Immunol Immunother Journal subject: ALERGIA E IMUNOLOGIA / NEOPLASIAS / TERAPEUTICA Year: 2023 Document type: Article Affiliation country: Estados Unidos Country of publication: Alemania
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Non-Small-Cell Lung / Lung Neoplasms / Antineoplastic Agents Limits: Humans Language: En Journal: Cancer Immunol Immunother Journal subject: ALERGIA E IMUNOLOGIA / NEOPLASIAS / TERAPEUTICA Year: 2023 Document type: Article Affiliation country: Estados Unidos Country of publication: Alemania